Trial
NCT01821625
Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Texas Southwestern Medical Center
Collaborators
GlaxoSmithKline
Condition
Thrombocytopenia
Intervention
Eltrombopag
Why stopped
Interferon use for hepatitis C plummeted, eliminating the need for study drug.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-13